ArticlePDF Available

Review of Nanoemulsion Formulation and Characterization Techniques

Authors:

Abstract

Nanoemulsions are colloidal dispersion systems that are thermodynamically stable, composed of two immiscible liquids mixed along with emulsifying agents (surfactants and co-surfactants) to form a single phase. Nanoemulsions have extensively been investigated as drug delivery systems. This review aims to provide consolidated information regarding various formulation and characterization techniques developed for nanoemulsions. Nanoemulsions are formulated using two different methods, the persuasion method and the Brute force method. Various characterization techniques for nanoemulsions include determination of entrapment efficiency, particle size, polydispersity index, zeta potential as well as characterization through differential scanning calorimetry, Fourier-transform infrared spectroscopy and transmission electron microscopy. Nanoemulsions are further evaluated by studying in vitro drug release, in vitro permeation, stability and thermodynamic stability, shelf life, dispersibility, viscosity, surface tension, friccohesity, refractive index, percent transmittance, pH and osmolarity.
September-October 2018 Indian Journal of Pharmaceutical Sciences 781
Review Article
Nanoemulsions, also known as submicron emulsions,
ultrane emulsions and miniemulsions, are submicron
sized colloidal particulate systems considered as
thermodynamically and kinetically stable isotropic
dispersions, which consist of two immiscible liquids
like water and oil, stabilized by an interfacial lm
consisting of a suitable surfactant and co-surfactant
to form a single phase. A number of surfactants with
diverse characteristics (ionic or non-ionic) had been
used with such nanoemulsions. Most widely used
among them were nonionic surfactants (sorbitan
esters, polysorbates), anionic surfactants (potassium
laurate, sodium lauryl sulphate), cationic surfactants
(quaternary ammonium halide) and zwitterions
surfactants (quaternary ammonium halide). Early
nanoemulsions were oil-in-water (O/W) type
emulsions with average droplet diameter ranging from
50 to 1000 nm. Nanoemulsions more recently are
classied into three categories such as O/W type (oil is
dispersed in aqueous phase), water-in-oil (W/O) type
(water is dispersed in oil phase), and bi-continuous
(microdomains of water and oil are interdispersed
within the system). Transformation among these three
types can be attained by altering the components of
the emulsions. Multiple emulsions are also a type of
nanoemulsions, where both O/W and W/O emulsions
present simultaneously in one system. For stabilizing
these two emulsions, both hydrophilic and lipophilic
surfactants are used simultaneously. Nanoemulsions
offer various advantages over other dosage forms and
these advantages are, (1) increased rate of absorption,
(2) reduced variability in absorption, (3) protection
from oxidation and hydrolysis in O/W nanoemulsions,
(4) delivery of lipophilic drugs after solubilisation,
(5) aqueous dosage form for water insoluble drugs,
(6) enhanced bioavailability for many drugs, (7) ability
to incorporate both lipophilic and hydrophilic drugs,
(8) delivery systems to enhance efcacy while reduce
total dose and side effects, (9) as non-toxic and non-
irritant vehicles for skin and mucous membrane delivery
and (10) release control by permeation of drug through
liquid lm, whose hydrophilicity or lipophilicity as
well as thickness can be precisely controlled.
Review of Nanoemulsion Formulation and
Characterization Techniques
K. GURPREET AND S. K. SINGH*
Department of Pharmaceutical Sciences, Guru Jambheshwar University of Science and Technology, Hisar, Haryana-125 001,
India
Gurpreet, et al.: Formulation and Characterization of Nanoemulsion
Nanoemulsions are colloidal dispersion systems that are thermodynamically stable, composed of two
immiscible liquids mixed along with emulsifying agents (surfactants and co-surfactants) to form a single
phase. Nanoemulsions have extensively been investigated as drug delivery systems. This review aims to
provide consolidated information regarding various formulation and characterization techniques developed
for nanoemulsions. Nanoemulsions are formulated using two different methods, the persuasion method and
the Brute force method. Various characterization techniques for nanoemulsions include determination of
entrapment efciency, particle size, polydispersity index, zeta potential as well as characterization through
differential scanning calorimetry, Fourier-transform infrared spectroscopy and transmission electron
microscopy. Nanoemulsions are further evaluated by studying in vitro drug release, in vitro permeation,
stability and thermodynamic stability, shelf life, dispersibility, viscosity, surface tension, friccohesity,
refractive index, percent transmittance, pH and osmolarity.
Key words: Nanoemulsions, nanoemulsion characterization, entrapment efciency, droplet size
*Address for correspondence
E-mail: sksingh_gju@rediffmail.com
This is an open access article distributed under the terms of the Creative
Commons Attribution-NonCommercial-ShareAlike 3.0 License, which
allows others to remix, tweak, and build upon the work non-commercially,
as long as the author is credited and the new creations are licensed under
the identical terms
Accepted 02 July 2018
Revised 26 May 2017
Received 24 January 2017
Indian J Pharm Sci 2018;80(5):781-789
www.ijpsonline.com
September-October 2018
Indian Journal of Pharmaceutical Sciences
782
FORMULATION OF MICROEMULSIONS
A number of techniques had been adopted for
formulation of nanoemulsions such as high pressure
homogenization, microudization, phase inversion,
spontaneous emulsication, solvent evaporation and
hydrogel formation[1-4]. Multiple emulsions are usually
prepared using the double emulsion-solvent evaporation
technique. A variety of techniques had been utilized
for characterization of such nanoemulsions used as
drug delivery systems. Nanoemulsions are formulated
mainly using two primary methods, (a) the persuasion
method and (b) the Brute force method.
Persuasion method/phase inversion technique:
Nanoemulsion preparation by persuasion method
doesn’t require any external force, but instead it
involves formation of ne dispersions when phase
transitions occur by changing either the temperature
or composition while keeping the alternate parameter
constant. Persuasion method can be broadly categorised
as, (i) phase transition from near-optimum state via
change in single variable, which includes altering one
variable of formulation such as temperature or salinity
close to optimal value. Hydrophilic-lipophilic deviation
(HLD) for optimal value is close to centre level for a
system, for example, employing higher temperature
to microemulsion. (ii) Phase transition from near-
optimal state via change in multiple variables, meaning
altering more than one variable of formulation. For
example, employing higher temperature and including
an additional salt in a microemulsion. (iii) Catastrophic
inversion, an inversion of low internal phase emulsion
so that the internal phase converts to external phase.
(iv) Phase transition stabilized by liquid crystal
formation, which includes nanodroplets stabilization
from a state close to HLD-0 by liquid crystal formation.
Brute force method:
This method includes utilization of brute forces
for breaking the oil droplets into the nano range.
Instruments that have been utilized for formulation of
nanomeulsions include high pressure homogenizer,
high speed mixer, small pore membrane and high
frequency ultrasonic device. Nanoemulsion properties
like its small size, optical transparency and high kinetic
stability is not only dependent upon the composition
of variables but also on the processing variables like
emulsication time, degree of mixing, energy input
and emulsifying path. High-pressure homogenization
and microuidization methods are employed at both
industrial and laboratory scale for attaining very
small size of nanoemulsion by utilizing high pressure
equipment. Various other methods are also being
employed for preparation of nanoemulsion such as
ultrasonication and in situ emulsication. Various
techniques employed for preparation of nanoemulsion
are shown in Table 1[5-21].
High pressure homogenization:
Nanoemulsion preparation required high shear force,
therefore in this strategy high-pressure homogenizer
or piston homogenizer is utilized for production of
nanoemulsions with very small particle size (up to
1 nm). In this technique, a mixture is forced to pass
through an orice at a very high pressure ranging
from 500 to 5000 psi. The resultant product is further
subjected to intense turbulence and hydraulic shear
resulting into emulsion with extremely ne particles.
This has been proved to be the most efcient method
for nanoemulsion preparation but the only drawback
associated with this technique is high energy
consumption and rise in temperature of emulsion
during processing. For obtaining smaller particle
size, it also requires larger runs of homogenization
cycles. Yilmaz et al. formulated phytosphingosine
O/W nanoemulsions by employing high pressure
homogenization method and found out that droplet size
was decreased after 8 homogenisation cycles and such
nanoemulsion was stable for over 6 mo[22].
Microuidization:
This method employed a device known as
microuidizer that utilizes high pressure positive
displacement pump (500-20 000 psi) that pushes the
product out through the interaction chamber consisting
of stainless steel microchannels on the impingement
area resulting into formation of very small particles of
sub-micron range. The mixture is repeatedly circulated
through the microuidizer until the required particle
size is achieved. Resultant product is also passed
through the lter to separate smaller droplets from
larger ones and to obtain a uniform nanoemulsion.
Uluata et al. fabricated octadecane O/W nanoemulsions
using a microuidizer and observed that on increasing
the number of passes and homogenization pressure,
the droplet size decreased[23]. Goh et al. prepared
tocotrienol-rich fraction nanoemulsions by two step
homogenization where a primary coarse emulsion was
prepared by using a stirrer, which was further processed
using a microuidizer. They reported that the droplet
www.ijpsonline.com
Indian Journal of Pharmaceutical Sciences 783
September-October 2018
size reduced from 120 to 65.1 nm after passing through
10 homogenization cycles at an increased pressure[24].
Ultrasonication:
In this technique premixed emulsion is exposed to
agitation at ultrasonic frequency of 20 kHz reducing the
droplets to nanodroplets size. The resultant emulsion
is then passed through high shear region to form
droplets with uniform size distribution. Water jacket is
employed in this technique to regulate the temperature.
Sonotrodes also known as sonicator probe consisted
of piezoelectric quartz crystals as the energy providers
during ultrasonic emulsication. On application of
alternating electric voltage, these sonotrodes contract
and expand. Mechanical vibrations are produced
when the sonicator tip contacted the liquid resulting in
cavitation, which leads to collapse of vapour cavities
formed within the liquid. This technique is mainly
adopted when droplet size less than 0.2 μ is required.
Shi et al. formulated emodin-loaded nanoemulsion by
using ultrasonic emulsication method at a frequency
of 25 kHz and achieved mean diameter of emodin-
loaded nanoemulsion was found to be in the range of
10-30 nm[25].
Spontaneous emulsication:
This technique involved preparation of nanoemulsion
in 3 stages. The rst stage included formation of an
organic solution, comprising of oil and lipophilic
surfactant in water miscible solvent and hydrophilic
surfactant and then the O/W emulsion is formed
by injecting this organic phase into the aqueous
Technique Formulation Conclusions References
High pressure homogenization Oral lipid nanoemulsion
(primaquine)
Enhanced oral bioavailability, 10-200 nm
particle size [5]
Pseudoternary phase
diagram+spontaneous
emulsication method
Ramipril nanoemulsion Increased bioavailability, droplet size
80.9 nm [6]
High pressure homogenization O/W nanoemulsions Improved skin hydration and elasticity [7]
Spontaneous emulsication O/W nanoemulsion
(aceclofenac)
Nanoemulsion with potential for
transdermal delivery of aceclofenac [8]
Spontaneous emulsication Celecoxib nanoemulsion Enhanced physical and chemical stability
of celecoxib in nanoemulsion [9]
High pressure homogenization Lecithin-based nanoemulsions
(progesterone)
Improved permeation rates of progesterone
with long-term stability [10]
High pressure homogenization Prednicarbate nanoemulsion Increased chemical stability of the drug in
formulation [11]
Phase inversion temperature
method
Acyclovir-loaded multiple
W/O/W nanoemulsions
Excellent physicochemical stability for 6
mo at RT, mean droplet size of 100 nm [12]
Spontaneous
nanoemulsication method Clotrimazole nanoemulsion Improved solubility of clotrimazole, mean
globule size <25 nm [13]
Ultrasonic emulsication
method Basil oil nanoemulsion Nanoemulsions with droplet size of 29.6
nm, for food preservation [14]
Phase inversion composition
method Efavirenz nanoemulsion Enhanced bioavailability, globule size <30
nm [34]
High-pressure homogenizer Dimethyl silicone dry
nanoemulsion inhalation
Effective in acute lung injury, particle size
of 19.8 nm [15]
High-pressure homogenizer
Parenteral lecithin-based
nanoemulsions
(risperidone)
Enhanced brain availability of risperidone
with a mean particle size of 160 nm [28]
Microuidization method Pitavastatin-containing
nanoemulsions Enhanced permeation [16]
High-pressure
homogenization+ultrasound Nanoemulsion Reduced energy demand for emulsication,
low particle dimensions and higher stability [17]
Sonication method Saponin-stabilized quercetin-
loaded o/w nanoemulsion
Stable for 45 d at RT, mean particle size of
52±10 nm [18]
High-pressure homogenization Paclitaxel-baicalein
nanoemulsion Strategy to overcome multidrug resistance [19]
Nanoemulsion templating PLGA nanoparticles Imaging agents for biomedical purposes [20]
Spontaneous emulsication
method
Chitosan lms with
cinnamaldehyde nanoemulsions Good UV barrier properties [21]
TABLE 1: TECHNIQUES EMPLOYED FOR PREPARATION OF NANOEMULSIONS
www.ijpsonline.com
September-October 2018
Indian Journal of Pharmaceutical Sciences
784
phase under magnetic stirring. The organic solvent
was then removed in the third stage by evaporation.
Sugumar et al. formulated stable eucalyptus oil
nanoemulsion by adopting spontaneous emulsication
and the mean droplet size was found to be in the range
of 50-100 nm[26].
Solvent evaporation technique/hydrogel method:
In this technique, drug solution is prepared and
emulsied into another liquid (non-solvent for drug)
and then solvent is evaporated, which led to drug
precipitation. High speed stirrer can be employed for
regulating the crystal growth and particle aggregation.
Hydrogel method is very similar the solvent
evaporation method. The only difference from the
solvent evaporation method is that the drug solution in
this case is miscible with the drug antisolvent.
CHARACTERIZATION OF NANOEMULSIONS
Determination of encapsulation efciency:
For determining the amount of drug entrapped in
the formulation, weighed amount of formulation is
dispersed in organic solvent by ultrasonication
and the drug is extracted into suitable buffer.
Drug content is estimated by analysing the extract
spectrophotometrically at λmax of drug after making
suitable dilutions against suitable blank. The entrapment
efciency (EE) and loading efciency (LE) of the
drug can be calculated by using the following Eqns.
[27], drug EE = drug content in the product obtained
(mg)/total amount of drug added (mg)×100 and drug
LE = drug content in the product obtained (mg)/total
product weight (mg)×100. Drug content could also
be determined using reverse phase high-performance
liquid chromatography (HPLC) techniques. Singh et
al. employed this technique for nding primaquine
concentration and reported 95 % encapsulation
efciency of formulated nanoemulsion[5].
Determination of particle size and polydispersity
index (PDI):
The particle size and PDI of nanoemulsions are
analysed employing photon correlation spectroscopy
(PCS) using Malvern Zetasizer, which monitors the
variation in light scattering because of Brownian motion
of particles as function of time. PCS is based on the
principle that the particles with small size travels with
higher velocity as compared to particles with large size.
The laser beam gets diffracted by sub-micron particles
present in solution. Due to diffusion of particles, rapid
uctuations in laser scattering intensity occur around
a mean value at a xed angle and this is dependent
upon particle size. The calculated photoelectron time-
correlation function generates a histogram of the line
width distribution that can be related to the size of
particle. For measuring particle size, weighed amount
of formulation is dispersed in double-distilled water for
obtaining homogenous dispersion and that has to be
used instantly for measuring the particle size and PDI.
The PDI can range from 0 to 1, where 0 (zero) stands for
monodisperse system and 1 for a polydisperse particle
dispersion[28]. Đorđević et al. evaluated the particle
size and PDI of risperidone nanoemulsion by using
this method and reported mean particle size around
160 nm with mean size distribution less than 0.15[29].
Singh et al. has also adopted the same technique and
reported particle size of primaquine nanoemulsion in
the range of 20-200 nm[5].
Determination of zeta potential:
The zeta potential is a method for measuring surface
charge of particles when it is placed in liquid. Zeta
potential is used for predicting dispersion stability
and its value depends on physicochemical property
of drug, polymer, vehicle, presence of electrolytes
and their adsorption. It is measured by Malvern
Zetasizer instrument. For measuring zeta potential,
nanoemulsion is diluted and its value is estimated
from the electrophoretic mobility of oil droplets. Zeta
potential of ±30 mV is believed to be sufcient for
ensuring physical stability of nanoemulsion. Đorđević
et al. obtained zeta potential around –50 mV by using
Malvern Zetasizer for risperidone nanoemulsion[29].
Fourier-transform infrared spectroscopy (FTIR)
spectral analysis:
FTIR analysis can be carried out for the assessment
of drug excipient interaction, polymerization,
crosslinking as well as drug loading in the formulation.
It is also used for identifying the functional groups
with their means of attachment and the ngerprint of
the molecule. At low temperature a molecule exists in
ground state and on absorbing the radiant energy, they
get excited to higher energy states. IR spectroscopy
is based on determining this energy difference (∆E)
between the excited and ground states of the molecule.
For performing FTIR, sample can be prepared by
employing suitable method such as potassium bromide
pellet method, Nujol mulls and then sample is scanned
in FTIR at moderate scanning speed between 4000-
400 cm-1. Srilatha et al. conducted FTIR studies on pure
drug and glipizide nanoemulsion and reported absence
www.ijpsonline.com
Indian Journal of Pharmaceutical Sciences 785
September-October 2018
of drug excipient interactions (hence compatibility of
drug and excipient) as all the characteristics peaks of
drug appeared at same point in formulation[30].
Morphological study of nanoemulsion:
The morphological study of nanoemulsion is carried
by using transmission electron microscopy (TEM).
In TEM, a beam of electron is incident on a thin foil
specimen and passed through it. On interacting with
the specimen, these incident electrons transform into
unscattered electrons, elastically scattered electrons
or inelastically scattered electrons. The distance
among the objective lens and the specimen and among
the objective lens and its image plane regulates the
magnication. The electromagnetic lenses concerted
the unscattered or scattered electrons and cast them
onto a screen that produce amplitude-contrast picture, a
phase-contrast image, electron diffraction, or a phantom
picture of distinct darkness, which is dependent upon
the density of unscattered electrons. Bright eld
imaging at increasing magnication in combination
with diffraction modes used for disclosing the size
and form of nanoemulsion droplets. For performing
TEM, few drops of nanoemulsion or a suspension
of lyophilized nanoparticles is prepared in double-
distilled water and are placed onto holey lm grid and
immobilized. Excess solution has to be wicked off from
the grid following immobilization and stained. The
stained nanoparticles are then examined at particular
voltage[31]. Singh et al. studied surface morphology
characteristics of primaquine nanoemulsion by TEM
analysis and reported spherical shape of primaquine
nanoemulsion with smooth surface[5].
Atomic force microscope (AFM):
AFM is comparatively a new technique being used
these days for exploring the surface morphology of
nanoemulsion formulations. AFM is carried out by
diluting nanoemulsions with water followed by drop
coating of the diluted nanoemulsion on a glass slide.
Further the coated drops are dried in oven and scanned
at of 100 mV/s[32]. Drais et al. performed AFM study
on carvedilol nanoemulsion and found that the size
varied from 42 to 83 nm with good stability of the
formulation[33].
In vitro drug release study:
In vitro drug release studies help to estimate the in vivo
performance of drug formulation. The in vitro release
rate of a drug is usually studied on a USP dissolution
apparatus. Nanoemulsion or dried nanoparticles
containing drug equivalent to 10 mg were dispersed in
buffer and then it is introduced into dialysis membrane
pouches and placed in a ask containing buffer. This
study is carried out at 37±0.5° and a stirring speed of
50 rpm. Sample are withdrawn at periodic intervals
and each time replaced by the same volume of
fresh dissolution medium. Samples are then diluted
suitably and the absorbance of sample is measured
spectrophotometrically at a particular wavelength.
Absorbance of the collected sample is used for
calculating % drug release at different time intervals
using calibration curve[31]. Kotta et al. studied the
in vitro drug release prole of antiHIV drug
nanoemulsion using dissolution apparatus type-II and
reported 80 % drug release in 6 h[34].
In vitro skin permeation studies:
Keshary Chien-diffusion cell is used for investigating
in vitro and ex vivo permeation studies. For performing
permeation studies, abdominal skin of adult male rats
weighing 250±10 g is usually employed. The rat skin is
positioned between the donor and the receiver chambers
of diffusion cells. Temperature of receiver chambers
containing fresh water with 20 % ethanol is xed at
37° and the contents of the chamber are continuously
stirred at 300 rpm. The formulations are kept in the
donor chamber. At specic time intervals such as 2, 4,
6, 8 h, a certain amount (0.5 ml) of the solution from
the receiver chamber was removed for performing gas
chromatographic analysis and each time replaced with
an equivalent volume of fresh solution immediately.
Each sample is performed three times. Cumulative
corrections are done for obtaining total amount of
drug permeated through rat skins at each time interval
and are plotted against function of time. Slope of
plot is used for calculating the permeation rates of
drug at a steady-state[35]. Harwansh et al. used Franz
diffusion cell for assessing transdermal permeability of
glycyrrhizin through human cadaver skin and reported
increased permeability with nanoemulsion formulation
as compared to conventional gel[36].
Stability studies:
Stability studies are performed for assessing stability
of the drug substance under the inuence of a various
environmental factors like temperature, humidity
and light. The stability studies of nanoemulsion are
carried out after storing the formulation for 24 mo in
dispersed and freeze-dried state as per International
Conference on Harmonisation guidelines. The storage
conditions followed are ambient (25±2°/60±5 % RH),
www.ijpsonline.com
September-October 2018
Indian Journal of Pharmaceutical Sciences
786
refrigeration (5±3°) and freeze (–20±5°). The requisite
volume of nanoemulsion is stored in glass bottles and
is tightly sealed. Samples are withdrawn at predened
time interval and analysed for the characteristics such
as particle size, loading and EE and in vitro drug
release prole[26]. Singh et al. performed stability
studies on nanoemulsion and observed that no change
in viscosity, drug content and particle size when the
formulation was stored for 3 mo at 25°/60 % RH and
30°/65 % RH[5].
Shelf life determination:
For determining shelf life of a nanoemulsion,
accelerated stability studies are performed. The
formulations are stored at three distinct temperatures
and ambient humidity conditions (30°, 40° and 50±0.5°)
for almost 3 mo. After a particular time interval (0,
30, 60 and 90 d) samples are withdrawn and analysed
using HPLC at λmax for estimating the remaining drug
content. Samples withdrawn at zero time are used as
controls. The order of the reaction is determined by
this and after that the reaction rate constant (K) for the
degradation is calculated from the slope of the lines by
using following equation at each elevated temperature:
slope = −K/2.303, the logarithm values of K are plotted
at different elevated temperatures against the reciprocal
of absolute temperature (Arrhenius plot). From this
plot value of K at 25° is determined and it is further
used for calculating shelf life by putting the value in
following Eqn.: t0.9=0.1052/K25. Where t0.9 stands for
time required for 10 % degradation of the drug and it is
termed as shelf life[31]. Ali et al. determined the shelf life
of clobetasol propionate-loaded nanoemulsion around
2.18 y at room temperature (25°) and concluded that
the stability of clobetasol propionate can be augmented
by incorporating in a nanoemulsion[37]. Parveen et al.
reported that the shelf life of a silymarin nanoemulsion
to be around 3.8 y when stored in a refrigerator[38].
Thermodynamic stability studies:
Thermodynamic stability studies are usually carried
out in three steps. Firstly heating-cooling cycle, which
is performed for observing any effect on the stability
of nanoemulsion by varying temperature conditions.
Nanoemulsion is exposed to six cycles between 4°
(refrigeration temperature) and 40° by storing the
formulation at each temperature for not less than
48 h. The formulations which are stable at these
temperatures are further chosen for centrifugation
studies. Secondly, centrifugation study in which
the formulated nanoemulsions are centrifuged at
5000 rpm for 30 min and observed for phase separation
or creaming or cracking. Those which did not show any
sign of instability are subjected to freeze thaw cycle.
Thirdly, the freeze-thaw cycle, in which nanoemulsion
formulations are exposed to three freeze-thaw cycles
with temperature varying between –21° and +25°.
Formulations that show no signs of instability pass
this test and deemed to have good stability[6]. These
formulations are then subjected to dispersibility studies
for evaluating the efciency of self-emulsication.
Srilatha et al. performed thermodynamic studies on
glipizide nanoemulsion by subjecting it to three cycles
of stability and reported good physical stability of
nanoemulsion with no appearance of phase separation,
creaming or cracking[30].
Dispersibility studies:
Dispersibility studies for evaluating the efciency of
self-emulsication of nanoemulsion are carried out
by using a standard USP XXII dissolution apparatus
2.1 ml of each formulation is incorporated into 500 ml
of distilled water maintained at 37±0.5°. A standard
stainless steel dissolution paddle rotates at 50 rpm for
providing gentle agitation. In vitro performance of the
nanoemulsion formulations is evaluated visually by
using a grading system described below[6]. Grade A
nanoemulsions form rapidly within 1 min and appear to
be clear or bluish. Grade B nanoemulsions form rapidly
but are slightly less clear emulsions appear to be bluish-
white. Grade C nanoemulsions are ne milky emulsion
that form within 2 min. Grade D are those dull, greyish-
white emulsions that has a little oily appearance and
are slower to form (>2 min). Grade E nanoemulsions
display either poor or negligible emulsication with
large oil globules present on the surface.
Determination of viscosity:
Viscosity assessment is an important parameter for
physicochemical characterization of nanoemulsion.
Various instruments are employed for measuring
viscosity such as Ostwald viscometer, Hoeppler falling
ball viscometer, Stormer viscometer, Brookeld
viscometer and Ferranti-Shirley viscometer. Among
all these viscometer, Brookeld is the preferred
one for measuring the viscosity of nanoemulsion.
Determination of viscosities afrms whether the
system is O/W or W/O emulsion. Low viscosity of
systems shows that it is O/W type and high viscosity
shows that it is water in oil type system[28]. However,
currently survismeter has been the most widely
employed equipment as it measures surface tension,
www.ijpsonline.com
Indian Journal of Pharmaceutical Sciences 787
September-October 2018
viscosity, interfacial tension, contact angle, dipole
moment and particle size and hydrodynamic volumes
of the nanoemulsions[39]. Shaq et al. has determined
viscosity of ramipril nanoemulsion formulations by
using Brookeld cone and plate rheometer and reported
the viscosity of formulations as less than 21 cP with the
minimum viscosity of 10.68 cP[6].
Refractive index:
Refractive index tells how light propagates through
the medium and transparency of nanoemulsion.
Refractive index (n) of medium can be dened as ratio
of speed of wave (c) in reference medium to the phase
speed of wave (vp) in medium: n=c/vp. Refractive
index of the nanoemulsion can be determined by
Abbes type refractometer at 25±0.5° by placing a
drop of nanoemulsion on slide and comparing it with
refractive index of water (1.333). If refractive index
of nanoemulsion has equal refractive index as that of
water, then the nanoemulsion is considered to have
transparent nature[2,28]. Harika et al. measured the
refractive index of amphotericin B nanoemulsion by
Abbe refractometer and the value of refractive index
of the formulation was found to be similar to that of
the water[40].
Percent transmittance:
Percent transmittance of a formulated nanoemulsion is
estimated using UV spectrophotometer at a particular
wavelength with distilled water as a blank. If percent
transmittance of a nanoemulsion is found to be greater
than 99 %, then it is considered as transparent in
nature[31]. Harika et al. reported percent transmittance
of >97 % for a amphotericin B nanoemulsion
formulated[40].
pH and osmolarity measurements:
The pH meter is used for measuring the pH of a
nanoemulsion and microosmometer is used for
determining the osmolarity of emulsion, which is
based upon freezing point method. For performing this,
100 µl of nanoemulsion is transferred in microtube and
measurements are taken[41]. Morsi et al. measured the
pH of the acetazolamide nanoemulsion by pH meter
and found pH in the range of 4.9 to 5.5 thus claiming
it to be adequate and non-irritant for application to the
eye[42].
Dye solubilisation:
A water soluble dye is dispersible in an O/W globule
whereas it is soluble in the aqueous phase of the W/O
globule. Similarly an oil soluble dye is dispersible in
the W/O globule but soluble in the oily phase of the
O/W globule[3]. On adding water soluble dye to O/W
nanoemulsion, it will evenly takes up the colour
whereas if it is a W/O emulsion, dye will remain in
dispersed phase only and the colour will not spread
evenly. This can be seen with microscopic examination
of emulsion[4]. Laxmi et al. carried out this test on
artemether nanoemulsion by adding eosin yellow, a
water soluble dye to the formulation and examined it
under a microscope. They discovered that the aqueous
continuous phase was labelled with dye while the
oily dispersed phase remained unlabelled therefore
conrming the formed nanoemulsion as O/W type[43].
Dilutability test:
The rationale of dilution test is that continuous phase
can be added in larger proportion into a nanoemulsion
without causing any problem in its stability. Thus
O/W nanoemulsions are dilutable with water but W/O
nanoemulsions are not and go through a phase inversion
into O/W nanoemulsion. The W/O nanoemulsion can
be diluted with oil only[3,4]. Laxmi et al. performed
dilutability test on nanoemulsion by diluting it with
water and observed no sign of phase inversion and
precipitation thus claiming their nanoemulsion
formulation to be stable[43].
Conductance measurement:
The O/W nanoemulsions are highly conducting
because they have water in external phase whereas
W/O nanoemulsions are not conducting as they
have water in internal or dispersal phase. Electrical
conductivity measurements are very much benecial
for determining the nature of the continuous phase
and for detecting phase inversion phenomena. At
low volume fractions, increase in conductivity of
certain W/O nanoemulsion systems was observed
and such kind of behaviour is deduced as an indicator
of a percolative behaviour or ions exchange among
droplets prior to the development of bicontinuous
structures. Dielectric measurements are a great means
of exploring the structural and dynamic features of
nanoemulsion systems[3]. Conductometer is employed
for determining the conductance of nanoemulsion.
For carrying out conductance measurement, a pair of
electrodes is attached to a lamp and an electric source is
immersed into an emulsion. When the emulsion is O/W
type then water will conduct the current and lamp will
glow because of passage of current among connecting
www.ijpsonline.com
September-October 2018
Indian Journal of Pharmaceutical Sciences
788
electrodes. The lamp will not glow if it is water in oil
emulsion as oil in external phase does not conduct
the current[4]. Harika et al. performed conductivity
test on amphotericin B nanoemulsion using an
electroconductometer. They reported conductivity of
the formulations in the range of 454.2-552.3 µS/cm
and concluded the system to be O/W on the basis of
electroconductivity study[40].
Interfacial tension:
By measuring the interfacial tension, the formation and
the properties of nanoemulsion can be investigated.
Ultra low values of interfacial tension corresponds to
phase behaviour, mainly the coexistence of surfactant
phase or middle-phase nanoemulsions with aqueous
and oil phases in equilibrium. For determining ultra-
low interfacial tension spinning-drop apparatus is
used. Interfacial tensions are obtained by measuring
the shape of a drop of the low-density phase, rotating it
in cylindrical capillary lled with high-density phase[3].
Fluorescence test:
There are numerous oils that show uorescence under
UV light. If a W/O nanoemulsion is subjected to a
uorescence light under a microscope, the whole eld
will uoresces and if it is an O/W the uorescence will
be in spots[4].
In vivo studies:
In vivo studies can be performed by adopting suitable
animal model according to the activity chosen.
Srilatha et al. has performed antidiabetic activity on
glipizide nanoemulsion by choosing hyperglycaemia
model in which they rst induce diabetes in rats by
intraperitoneal injection of streptozotocin solution
and then the formulation was given to diabetic rats
and the pharmacodynamic studies were performed on
them. They reported the reduction in blood glucose
levels for up to 12 h[30]. Chouksey et al. has evaluated
in vivo performance of atorvastatin nanoemulsion by
performing pharmacokinetic studies on nanoemulsion
and they reported better bioavailability of nanoemulsion
formulation as compared to pure drug[44].
Nanoemulsions hold great potential as an efcient
drug delivery tool that could be effectively harnessed
to realise the complete potential. Quality assurance and
quality control shall be of paramount importance with
such a precise delivery system and hence the evaluation
tests are to be performed rigorously.
Acknowledgements:
Authors thanks UGC, New Delhi, for awarding Rajiv
Gandhi National Fellowship.
Conicts of interest:
There are no conicts of interest among the authors.
REFERENCES
1. Nigade PM, Patil SL, Tiwari SS. Self-emulsifying drug
delivery system (SEDDS): A Review. Int J Pharm Biol Sci
2012;2:42-52.
2. Kumar S. Role of nano-emulsion in pharmaceutical sciences-a
review. AJRPSB 2014;2:1-15.
3. Bhosale RR, Osmani RA, Ghodake PP, Shaikh SM, Chavan
SR. Nanoemulsion: A Review on novel profusion in advanced
drug delivery. Indian J Pharm Biol Res 2014;2:122-7.
4. Jaiswal M, Dudhe R, Sharma PK. Nanoemulsion: an advanced
mode of drug delivery system. 3 Biotech 2015;5:123-7.
5. Singh KK, Vingkar SK. Formulation, antimalarial activity and
biodistribution of oral lipid nanoemulsion of primaquine. Int J
Pharm 2008;347:136-43.
6. Shaq S, Shakeel F, Talegaonkar S, Ahmad FJ, Khar RK,
Ali M. Development and bioavailability assessment of
ramipril nanoemulsion formulation. Eur J Pharm Biopharm
2007;66:227-43.
7. Yilmaz E, Borchert HH. Effect of lipid-containing, positively
charged nanoemulsions on skin hydration, elasticity and
erythema- an in vivo study. Int J Pharm 2006;307:232-38.
8. Shakeel F, Baboota S, Ahuja A, Ali J, Aqil M, Shaq S.
Nanoemulsions as vehicles for transdermal delivery of
aceclofenac. AAPS Pharm Sci Tech 2007;8(4):E104.
9. Shakeel F, Baboota S, Ahuja A, Ali J, Aqil M, Shaq S.
Accelerated stability testing of celecoxib nanoemulsion
containing Cremophor-EL. Afr J Pharm Pharmacol
2008;2:179-83.
10. Klang V, Matsko N, Zimmermann AM, Vojnikovic E, Valenta
C. Enhancement of stability and skin permeation by sucrose
stearate and cyclodextrins in progesterone nanoemulsions. Int
J Pharm 2010;393:153-61.
11. Baspinar Y, Keck CM, Borchert HH. Development of a
positively charged prednicarbate nanoemulsion. Int J Pharm
2010;383:201-08.
12. Schwarz JC, Klang V, Karall S, Mahrhauser D, Resch GP,
Valenta C. Optimisation of multiple W/O/W nanoemulsions
for dermal delivery of acyclovir. Int J Pharm 2012;435:69-75.
13. Borhade V, Pathak S, Sharma S, Patravale V. Clotrimazole
nanoemulsion for malaria chemotherapy. Part I: Preformulation
studies, formulation design and physicochemical evaluation.
Int J Pharm 2012;431:138-48.
14. Ghosh V, Mukherjee A, Chandrasekaran N. Ultrasonic
emulsication of food-grade nanoemulsion formulation and
evaluation of its bactericidal activity. Ultrason Sonochem
2013;20:338-44.
15. Zhu L, Li M, Dong J, Jin Y. Dimethyl silicone dry
nanoemulsion inhalations: Formulation study and anti-acute
lung injury effect. Int J Pharm 2015;491:292-8.
16. Başpınar Y, Gündoğdu E, Köksal C, Karasulu E. Pitavastatin-
containing nanoemulsions: Preparation, characterization and
in vitro cytotoxicity. J Drug Deliv Sci Technol 2015;29:117-24.
17. Calligaris S, Plazzotta S, Bot F, Grasselli S, Malchiodi A,
www.ijpsonline.com
Indian Journal of Pharmaceutical Sciences 789
September-October 2018
Anese M. Nanoemulsion preparation by combining high
pressure homogenization and high power ultrasound at low
energy densities. Food Res Int 2016;83:25-30.
18. Kaur K, Kumar R, Mehta SK. Formulation of saponin
stabilized nanoemulsion by ultrasonic method and its role to
protect the degradation of quercetin from UV light. Ultrason
Sonochem 2016;31:29-38.
19. Meng L, Xia X, Yang Y, Ye J, Dong W, Ma P, et al. Co-
encapsulation of paclitaxel and baicalein in nanoemulsions
to overcome multidrug resistance via oxidative stress
augmentation and P-glycoprotein inhibition. Int J Pharm
2016;513:8-16.
20. Fornaguera C, Feiner-Gracia N, Calderó G, García-Celma
MJ, Solans C. PLGA nanoparticles from nano-emulsion
templating as imaging agents: Versatile technology to obtain
nanoparticles loaded with uorescent dyes. Colloids Surf B
Biointerfaces 2016;147:201-9.
21. Chen H, Hu X, Chen E, Wu S, McClements DJ, Liu S, et
al. Preparation, characterization, and properties of chitosan
lms with cinnamaldehyde nanoemulsions. Food Hydrocoll
2016;61:662-71.
22. Yilmaz E, Borchert HH. Design of a phytosphingosine-
containing, positively-charged nano- emulsion as a colloidal
carrier system for dermal application of ceramides. Eur J
Pharm Biopharm 2005;60:91-8.
23. Uluata S, Decker EA, McClements DJ. Optimization of
nanoemulsion fabrication using microuidization: role of
surfactant concentration on formation and stability. Food
Biophys 2016;11:52-9.
24. Goh PS, Ng MH, Choo YM, Amru NB, Chuah CH. Production
of nanoemulsions from palm-based tocotrienol rich fraction
by microuidization. Molecules 2015;20:19936-46.
25. Shi Y, Li H, Li J, Zhi D, Zhang X, Liu H, et al. Development,
optimization and evaluation of emodin loaded nanoemulsion
prepared by ultrasonic emulsication. J Drug Deliv Sci
Technol 2015;27:46-55.
26. Sugumar S, Mukherjee A, Chandrasekaran N. Nanoemulsion
formation and characterization by spontaneous emulsication:
Investigation of its antibacterial effects on Listeria
monocytogenes. Asian J Pharm 2015;9:23-8.
27. Bhagav P, Upadhyay H, Chandran S. Brimonidine tartrate
Eudragit long-acting nanoparticles: formulation, optimization,
in vitro and in vivo evaluation. AAPS PharmSciTech
2011;12:1087-101.
28. Baboota S, Shakeel F, Ahuja A, Ali J, Shaq S. Design
development and evaluation of novel nanoemulsion
formulations for transdermal potential of Celecoxib. Acta
Pharm 2007;57:315-32.
29. Đorđević SM, Cekić ND, Savić MM, Isailović TM, Ranđelović
DV, Marković BD, et al. Parenteral nanoemulsions as
promising carriers for brain delivery of risperidone: Design,
characterization and in vivo pharmacokinetic evaluation. Int J
Pharm 2015;493:40-54.
30. Srilatha R, Aparna C, Srinivas P, Sadanandam M. Formulation,
evaluation and characterization of glipizide nanoemulsions.
Asian J Pharm Clin Res 2013;6:66-71.
31. Bali V, Ali M, Ali J. Study of surfactant combinations and
development of a novel nanoemulsion for minimising
variations in bioavailability of ezetimibe. Colloids Surf B
Biointerfaces 2010;76:410-20.
32. Karthikeyan S, Jeeva PA, Jerobin J, Mukherjee A,
Chandrasekaran N. Formulation and characterization of
nanoemulsion coatings from Azadirachta indica. Int J
ChemTech Res 2012;4:566-70.
33. Drais HK, Hussein AA. Formulation and characterization of
carvedilol nanoemulsion oral liquid dosage form. Int J Pharm
Pharm Sci. 2015;7:209-16.
34. Kotta S, Khan AW, Ansari SH, Sharma RK, Ali J. Anti HIV
nanoemulsion formulation: Optimization and in vitro-in vivo
evaluation. Int J Pharm 2014;462:129-34.
35. Kuo F, Subramanian B, Kotyla T, Wilson TA, Yoganathan
S, Nicolosi RJ. Nanoemulsion of an antioxidant synergy
formulation containing gamma tocopherol have enhanced
bioavailability and anti-inammatory properties. Int J Pharm
2008;363:206-13.
36. Harwansh RK, Patra KC, Pareta SK, Singh J, Rahman MA.
Nanoemulsions as vehicles for transdermal delivery of
glycyrrhizin. Braz J Pharm Sci 2011;47:769-78.
37. Ali MS, Alam MS, Alam N, Anwer T, Safhi MM. Accelerated
stability testing of a clobetasol propionate-loaded nanoemulsion
as per ICH guidelines. Sci Pharm 2013;81:1089-100.
38. Parveen S, Baboota S, Ali J, Ahuja A, Ahmad S. Stability
studies of silymarin nanoemulsion containing Tween 80 as a
surfactant. J Pharm Bioallied Sci 2015;7:321-4.
39. Malik P, Ameta RK, Singh M. Preparation and characterization
of bionanoemulsions for improving and modulating the
antioxidant efcacy of natural phenolic antioxidant curcumin.
Chem Biol Interact 2014;222:77-86.
40. Harika K, Debnath S, Babu MN. Formulation and evaluation
of nanoemulsion of amphotericin B. IJNTPS 2015;5:114-22.
41. Gué E, Since M, Ropars S, Herbinet R, Le Pluart L,
Malzert-Fréon A. Evaluation of the versatile character of a
nanoemulsion formulation. Int J Pharm 2016;498:49-65.
42. Morsi NM, Mohamed MI, Refai H, El Sorogy HM.
Nanoemulsion as a novel ophthalmic delivery system for
acetazolamide. Int J Pharm Pharm Sci 2014;6:227-36.
43. Laxmi M, Bhardwaj A , Mehta S, Mehta A. Development
and characterization of nanoemulsion as carrier for the
enhancement of bioavailability of artemether. Artif Cells
Nanomed Biotechnol 2015;43:334-44.
44. Chouksey R, Jain AK, Pandey H, Maithil A. In vivo assessment
of atorvastatin nanoemulsion formulation. Bull Pharm Res
2011;1:10-4.
... The state of the separated phase less than a micron also plays a part in creation of transparent or translucent products. When used in combination with fluidity, it holds nicely on the skin, making nanoemulsions suitable for fluid cosmetics such as lotion or transparent milk [53][54][55]. After topical application, nanoemulsions coat the skin smoothly, without leaving a glossy coating or creaming effect and without dissolving into their constituent parts [39]. ...
... For skin problems resulting from UV rays, lycopene and propolis aqueous extract were tried in order to determine their impact on UV protection but they exhibited poor result. The use of nanoemulsions with the appropriate proportions of the surfactants improved skin compatibility, safety, and therapeutic effect of these extracts [53]. ...
... Oil/water (O/W) nanoemulsions were prepared using the ultrasonic emulsification method (Gurpret;Singh, 2018), following three steps: 1) preparation of the aqueous phase (90%), composed of the BSAW suspension (30% by weight) and distilled water (60% by weight), followed by vigorous stirring (magnetic stirrer model RT 15 P, IKA) for 1 hour; 2) preparation of oily phase (10%), composed of 1 mL of copaiba oil, added to the aqueous phase with subsequent vigorous stirring for 6 hours; and ...
Article
Full-text available
Copaíba (Copaifera L.) e andiroba (Carapa guianensis Aubl.) são árvores tropicais nativas da região amazônica, comumente processadas para extrair óleos com diversas aplicações nutricionais, econômicas e farmacológicas. Esses óleos exibem propriedades antimicrobianas contra uma ampla gama de bactérias, incluindo aquelas responsáveis pela mastite bovina, uma condição inflamatória prevalente que afeta as glândulas mamárias das vacas. No entanto, devido à sua natureza hidrofóbica, a formulação de terapias eficazes usando esses óleos apresenta desafios. Além disso, o descarte inadequado de subprodutos do processamento dessas árvores, particularmente a andiroba, resulta em repercussões econômicas, sociais e ambientais significativas. Este estudo investigou o uso potencial da biomassa residual do processamento do fruto da andiroba para a produção de um biossurfactante ramnolipídico pela bactéria Pseudomonas aeruginosa, designada como BSAW. O BSAW serve como um agente estabilizador e formador para uma nanoemulsão óleo-água contendo óleo de copaíba (NEBSAW) por meio de métodos de alta energia, com propriedades antibacterianas contra bactérias causadoras de mastite bovina. Demonstrando índices favoráveis de rendimento e atividade emulsificante, o BSAW auxiliou no encapsulamento do óleo de copaíba, garantindo a estabilidade física do NEBSAW e aumentando seu efeito antimicrobiano, particularmente contra Streptococcus agalactiae, Klebsiella spp. e Corynebacterium bovis. Este estudo destacou o potencial de aproveitar a biomassa residual do processamento de frutas amazônicas para desenvolver bioprodutos ecologicamente corretos e comercialmente competitivos. Esta abordagem fortalece o valor dos biossurfactantes ramnolipídicos como alternativas ambientalmente viáveis para o desenvolvimento de nanoemulsões, acentuando a importância da biodiversidade regional no fomento de soluções inovadoras e ecologicamente conscientes.
... As indicators, zero-time samples were used. At each time interval, 1 mL of each formulation was taken and diluted to 5 mL with methanol, then quantified using a UV spectrophotometer at 256nm (176,177) . the animal nasal and oral doses for the rabbit as follows (178) : ...
Thesis
Full-text available
Abstract Lasmiditan (LAS) suffers from low oral bioavailability which is around 40% resulting from it being extensively metabolized by non-CYP enzymes (extensive pre-systemic-metabolism) as well as LAS is P-glycoprotein (p-gp) efflux system's substrate in the intestinal wall, that was the onset of action of LAS delayed. This study aimed to improve LAS bioavailability via formulation as nano-emulsion-based in situ gel (NEIG) given intranasally to achieve rapid onset with a higher extent of drug absorption (higher bioavailability). The solubility of LAS in different oils, surfactants, and co-surfactants, was determined. Using oleic acid (OA), Labrasol (LR), Cremophore(CE), Transcutol (TC), and deionized water (DD), eight-phase diagrams were constructed with different surfactant type and S-mix ratio, to identify the nano-emulsification region. Thirty-eight LAS nano-emulsions (NEs) were prepared using the spontaneous emulsification method with ultrasonication. Visual Characterization, Thermodynamic stability study, globule size, polydispersity index (PDI), drug content as well and in vitro release, all were measured to predict the optimum formulations that pass through the ex vivo studies. F15 (NE a), and F31(NE b) are the only successfully prepared NE formulas that were selected for the incorporation of different percentages of pH-sensitive in situ gelling polymer (Carbopol 934) to prepare NEIGs 1, 2, 3, 4, 5, and 6. The pH, gelation capacity, gel strength, and viscosity were predicted for the prepared NEIGs. The release (in-vitro) and the nasal permeation (ex-vivo) were determined for NEIG 2 and 5, then both were subjected to pharmacokinetics in vivo studies using 18 male rabbits weighing 1.8-2.0 kg. The body surface area (BSA) normalization method was applied for LAS dose calculation. Serial blood samples were taken out and subjected to drug analysis via the HPLC method. Primary pharmacokinetics parameters, including maximum drug concentration in plasma (C-max), time to reach C-max (T-max), and area under the concentration-time curve from time zero to last time intervals (AUCt0-l9) were calculated. Even though the majority of the produced NEs had globule sizes ranging from 45 to 140 nm and appeared to be thermodynamic stable, having suitable optical transparency of 95–98%, and polydispersity of 0.253–0.382, were passed through in-vitro released to select only 9 NEs (F1, F7, F14, F15, F18, F19, F24, F31 and F34) which achieve 100% released at the end of 25 min. All were passed through an ex-vivo permeation study to optimize only two F15 (NE a), and F31(NE b) with the highest flux values respectively) and significantly higher values of the permeability coefficient (2.32, and 2.37 mg/cm2.min with 2.97x10-2, and 2.9 x10-2 respectively) relative to the other NEs. Different % of Carbopol 934 with the optimization of 0.5% as the best ratio to be incorporated with the aqueous part of the NEs. As a result of the in-vitro evaluation of in situ gel NEIG 2(10% OA, 50% CE: TC at 1:2 ratio with 0.5% Carbopol suspended in 40% DD), and NEIG 5 (15% OA, 55% LR: TC at 3:1 ratio with w 0.5% Carbopol suspended in 30% DD) were selected to be a substrate for in-vitro release and ex-vivo permeation studies. Both NEIG 2 and 5 achieved a maximum permeation 3.3 folds higher as compared to the AQS as well and they exert more residence time to overcome the normal nasal physiological clearance. The values of C-max, T-max, and AUC0- 19 for NEIG 2 and NEIG 5 were 8066±242 ng/ml, 0.75±0.05 h, 19616.86±589 ng. h/ml, and 7975.67±239 ng/ml, 1.0±0.05 h, 17912.36±537 ng. h/ml respectively compared with the traditional AQS which is equal to 4181.09±125 ng/ml, 2±0.2 h, and 8852.27±266 ng. h/ml. NEIG 2 and 5 had better Intranasal delivery of LAS and can significantly (p<0.05) improve the extent of drug absorption (C max and AUC t 0-19) by 2.5 folds at a faster rate (rapid onset) compared to AQS optimum formula. In conclusion, NEIG 2 and NEIG 5 are promising intranasal new formulas with improving bioavailability (rapid T max and higher C max) than the oral dosage form (AQS), although the selected optimum golden formula that will be ready for further clinical study is NEIG 2.
... These additives modify the properties of the emulsifier, thereby triggering a phase inversion that results in the formation of nanoemulsions [62]. iii Spontaneous emulsification, also known as the Ouzo effect, is a process in which rapid changes in interfacial tension result in the spontaneous formation of small droplets as a solvent phase mixes with an immiscible phase [61,63,64]. iv Emulsion Inversion Point (EIP) technique involves the creation of a water-in-oil (W/O) emulsion with a high oil-to-water ratio. ...
Article
Full-text available
Foodborne diseases are one of the most serious problems the food sector has to confront, while questions have been raised concerning the effects of several antimicrobial additives on consumer health. Nisin is a peptide produced primarily by Lactococcus lactis with antimicrobial properties mostly against Gram-positive bacteria. It is generally recognized as safe (GRAS) for use in a wide range of food categories. However, its interaction with components of the food matrix, its susceptibility to proteolytic degradation, or the competitive presence of other components may limit its activity. To enhance its effectiveness against Gram-negative bacteria, its combination with essential oils or other antimicrobial components has been investigated. In addition, its encapsulation in several types of nano-delivery systems has been used to protect nisin from food matrix sequestering while regulating its release. In this review, we present how nisin is utilized, alone or in combination with other antimicrobial agents in a range of emulsion types, as well as the standard techniques for the physicochemical characterization of these systems.
Article
Antimicrobial resistance and oral dysbiosis often reduce the efficacy of conventional antimicrobial treatments. In addition, poor permeability and insufficient accumulation of therapeutic agents in biofilms are the main causes of failure in the treatment of oral infections. Antimicrobial photodynamic therapy (PDT) is a versatile therapeutic approach that uses light-activated photosensitizers to fight bacterial infections. When irradiated with light of a specific wavelength, photosensitizers generate reactive oxygen species that selectively damage microbial cells. However, most photosensitizers are poorly soluble in water, which limits their clinical application. Nanotechnology offers a promising solution by incorporating nanocarriers into PDT. Nanocarriers can play a crucial role in improving PDT by overcoming the limitations of conventional photosensitizers. They can encapsulate photosensitizers, protect them from premature degradation, and improve their penetration and delivery to target sites. In this review, different drug delivery systems based on nanocarriers are investigated to improve the efficacy of PDT in dental applications.
Article
Diclofenac sodium is the most widely prescribed NSAIDs, but it has side effects on the GI tract. To overcome this, it can be formed in topical delivery. Diclofenac sodium is included in BCS class II with a log P value of 1.1. Diclofenac sodium can be designed in a nanoemulsion system to increase solubility and penetration effect on the skin. Nanoemulsion is a novel drug delivery consisting of two immiscible liquids, water and oil, which are stabilized by surfactant and cosurfactant. The components ratio of nanoemulsion must be appropriately combined to produce desirable properties, including small particle sizes and stable systems. Determining their optimal ratio is possible via the simplex lattice design (SLD) method. The SLD method was utilized as an optimization technique to generate model formulations of nanoemulsions by the nanoemulsion region extracted from the pseudo-ternary phase diagram. Nanoemulsion was prepared between water, oleic acid (oil), Tween 80-Span 80 (surfactant), and ethanol (cosurfactant) by low energy emulsification method. Their characteristics were evaluated. Tween 80-Span 80 and ethanol with a 2:1 ratio was chosen because they showed maximum nanoemulsion region. The optimal nanoemulsion formulation comprises 15.28% water, 21.25% oil, and 63.47% emulsifier. The results of nanoemulsion characteristics were good, with 108.8 nm particle size, 0.443 PDI, 99.8% transmittance, and 5.276 pH. The observed values were not significantly different from the predicted values. The utilization of the simplex lattice design method in the optimization of nanoemulsions is advantageous for the advancement of pharmaceutical development.
Article
Nanoemulsions, which are submicron-sized emulsions with droplet sizes between 20 and 200 nm, have attracted a lot of interest in a lot of different disciplines because of their special qualities, which include increased bioavailability, stability, and large surface area. This article offers a thorough analysis of the creation, properties, and range of uses for nanoemulsions. The formulation section explores the different ways to prepare nanoemulsions, emphasizing both high-energy and low-energy methods. It also covers important aspects that affect the stability and performance of these techniques, like the composition of the oil phase, the choice of surfactant, and process parameters. The roles of several characterization techniques in determining droplet size, distribution, zeta potential, and other physicochemical parameters are addressed, including dynamic light scattering (DLS), electron microscopy, and rheology. The range of applications for nanoemulsions being investigated, including medicine, where they provide drug solubility and targeting, the food industry for better nutritional absorption and stability, the cosmetics business for improved active ingredient delivery, and the environmental sectors for their roles in pollutant clean up. The paper also discusses the field's obstacles and opportunities going forward, highlighting the necessity of established procedures and a greater comprehension of nanoemulsion behavior in intricate biological and environmental systems. By means of this thorough investigation, the review hopes to offer a fundamental resource for practitioners and researchers that deal with nanoemulsions, encouraging creativity and useful breakthroughs in their respective domains.
Article
Full-text available
المستحلبات النانوية هي انظمة تشتت غروية تجمع بين سائلين غير قابلين للامتزاج مع عوامل استحلاب ( مواد خافضة للتوتر السطحي) لإنتاج مركب ممتزج مستقر ديناميكيا . انها توفر العديد من الخيارات لتوصيل الادوية خلال الحواجز المحبة للدهون . العديد من المركبات الطبيعية والمصنعة تم انتاجها باستخدام هذا النوع من انظمة التوصيل بهدف تحسين فعاليتها الحيوية ,نقلها و استقراريتها . هذا البحث يركز على دور عوامل الاستحلاب في تركيب المستحلبات النانوية بمختلف انظمة النقل الدوائية والذي يتضمن تأثير نوع و تركيز عوامل الاستحلاب نوع المستحلب النانوي و نظام النقل الدوائي
Article
Bromocriptine (BCM), a dopaminergic agonist used in Parkinson's disease treatment, has poor oral bioavailability due to extensive first-pass metabolism and limited gastrointestinal absorption. This study aimed to develop a β-cyclodextrin-functionalized bromocriptine nanoemulsion (oil-in-water) to enhance drug solubility, stability, and bioavailability while facilitating direct brain delivery via the intranasal route. The formulation was designed to overcome systemic metabolic barriers, improve drug permeation across the blood-brain barrier, and ensure sustained therapeutic effects with minimal systemic side effects. Nano-emulsions were prepared using high-shear homogenization. Characterization was performed using scanning electron microscopy (SEM) for morphological analysis. Globule size and zeta potential were measured using Malvern Zetasizer. Fourier Transform Infrared Spectroscopy (FTIR) was used for structural analysis, while X-ray diffraction (XRD) assessed crystallinity. Differential Scanning Calorimetry (DSC) was conducted for thermal analysis. Drug content and in-vitro drug release were evaluated using UV-visible spectroscopy. Stability studies were performed using centrifugation and freeze-thaw methods. Docking studies and Histopathological evaluation were also performed of the prepared formulations. Morphological studies revealed nano-sized globular particles with a mean diameter of 117.2 nm and a low polydispersity index (PDI 0.810), indicating uniformity. The nanoemulsion exhibited a zeta potential of -10.5 mV, ensuring colloidal stability. The encapsulation efficiency (EE%) of the optimized formulation (F4) was 95.36(% w/w,) with a drug load of approximately 9.5(% w/w). In-vitro drug release reached 85.65%, with permeation release of 78.44% and 70.13% ex-vivo. The formulation remained stable under freeze-thaw and centrifugation conditions. Cell toxicity assessments demonstrated excellent biocompatibility, with no significant cytotoxic effects observed in histopathological evaluations. This nanoemulsion presents a promising alternative to oral bromocriptine for Parkinson's treatment.
Article
This research focuses on the assessment of cytotoxic and antimicrobial properties of Thymus capitatus essential oil (TEO) and Origanum vulgare essential oil (OEO), before and after encapsulation in nanoemulsions, prepared utilizing high-pressure homogenization. These plants, indigenous to northern Albania and Mediterranean regions, produce EO with notable biological and cytotoxic activities. However, volatility, poor solubility, and chemical instability limit their practical application. Incorporating these oils into NE aims to enhance their stability and biological activity. The antimicrobial efficacy of the EO exhibited variability against different strains, showing particular effectiveness against E. coli ATCC 25922, S. aureus ATCC 29213, and C. albicans ATCC 10231, with no effect was observed against P. aeruginosa ATCC 27853. The EO-loaded NE exhibited enhanced cytotoxicity against MCF7, DU 145, and HT-29 cancer cell lines compared to the free oil. Encapsulation was found to augment the bioactivity of these volatile oils, with TEO-NE demonstrating superior cytotoxic effects than OEO-NE. Following encapsulation, OEO exhibited superior antimicrobial efficacy relative to TEO against S. aureus, E. coli, and C. albicans. Our results suggest that NE may enhance the cytotoxic and antimicrobial potential of the EOs, in different manner among EO used. The encapsulation of TEO and OEO in NE shows promising therapeutic potential, although further studies are required. However, these conclusions are drawn from in vitro analyses, underscoring the need for subsequent in vivo studies to ascertain this innovative clinical safety and efficacy.
Article
Multidrug resistance (MDR) is a major obstacle for clinical application of paclitaxel (PTX). Recent studies have suggested that baicalein (BA) might be a potent MDR reversal agent with the ability of P-glycoprotein inhibition and oxidative stress augmentation. Herein, we co-encapsulated PTX and BA in nanoemulsions (PTX/BA NE) for overcoming MDR in breast cancer. Paclitaxel-cholesterol complex and baicalein-phospholipid complex were prepared to improve the liposolubility of PTX and BA. The cytotoxicity of the combination of PTX and BA with different weight ratios were evaluated and the combination with a weight ratio of 1/1 exhibited the strongest synergistic effect. In vitro cytotoxicity study indicated that PTX/BA NE had a better antitumor efficacy in MCF-7/Tax cells than other PTX formulations. Studies on cellular uptake demonstrated that the PTX/BA NE could effectively accumulate in cancer cells. Mechanism research showed that PTX/BA NE could significantly increase the cellular reactive oxygen species (ROS), decrease cellular glutathione (GSH), and enhance caspase-3 activity in MCF-7/Tax cells. More importantly, in vivo antitumor study demonstrated that PTX/BA NE exhibited a much higher antitumor efficacy than other PTX formulations. These findings suggest that co-delivery of PTX and BA in nanoemulsions might provide us a potential combined therapeutic strategy for overcoming MDR.
Article
The interest in polymeric nanoparticles as imaging systems for biomedical applications has increased notably in the last decades. In this work, PLGA nanoparticles, prepared from nano-emulsion templating, have been used to prepare novel fluorescent imaging agents. Two model fluorescent dyes were chosen and dissolved in the oil phase of the nano-emulsions together with PLGA. Nano-emulsions were prepared by the phase inversion composition (PIC) low-energy method. Fluorescent dye-loaded nanoparticles were obtained by solvent evaporation of nano-emulsion templates. PLGA nanoparticles loaded with the fluorescent dyes showed hydrodynamic radii lower than 40nm; markedly lower than those reported in previous studies. The small nanoparticle size was attributed to the nano-emulsification strategy used. PLGA nanoparticles showed negative surface charge and enough stability to be used for biomedical imaging purposes. Encapsulation efficiencies were higher than 99%, which was also attributed to the nano-emulsification approach as well as to the low solubility of the dyes in the aqueous component. Release kinetics of both fluorescent dyes from the nanoparticle dispersions was pH-independent and sustained. These results indicate that the dyes could remain encapsulated enough time to reach any organ and that the decrease of the pH produced during cell internalization by the endocytic route would not affect their release. Therefore, it can be assumed that these nanoparticles are appropriate as systemic imaging agents. In addition, in vitro toxicity tests showed that nanoparticles are non-cytotoxic. Consequently, it can be concluded that the preparation of PLGA nanoparticles from nano-emulsion templating represents a very versatile technology that enables obtaining biocompatible, biodegradable and safe imaging agents suitable for biomedical purposes.
Article
Natural aldehydes, such as cinnamaldehyde, can be used to modify the properties of chitosan-based materials by covalent cross-linking the chitosan molecules. Due to the non-polarity and hydrophobicity of cinnamaldehyde, emulsification technique was used to prepare homogeneous cinnamaldehyde-chitosan films. Under optimized conditions, cinnamaldehyde nanoemulsions led to the successful fabrication of uniform and smooth chitosan films. FTIR analysis of the films indicated the formation of chitosan-cinnamaldehyde Schiff base. The cross-linked films strongly absorbed UV-visible light and inhibited the emission of fluorescent light, and may therefore provide good photo-protection. The thickness (26–61 μm) and transparency (clear to turbid) of the chitosan films were modulated by varying the aldehyde/amino group ratio. The mechanical properties and water vapor permeability of the films also depended on the amount of cinnamaldehyde nanoemulsion utilized. Chitosan films showed good antimicrobial activity, but had better antifungal than antibacterial activity.
Article
Objective: Carvedilol is antihypertensive. It is practically water insoluble. Therefore, the objective of this investigation is a formulation and characterization of carvedilol nano emulsion (NE) employing orally to increase carvedilol solubility for enhancing of carvedilol bioavailability. Methods: The formulation components were chosen according to the solubility study. The diagrams of pseudo-ternary phase were made using the aqueous phase titration method. The formulated nanoemulsions were subjected to various thermodynamic stability assays. We selected eight of formulas that have thermodynamic stability for further optimization for various characterizations in order to select the best formula. Results: The carvedilol NE3 considered a selected formula. It composes of 1.25 mg carvedilol per g of the nanoemulsion, 10% of peppermint oil, 20% of tween80, 10% ethanol and 60% of distilled water. It was characterized by a low globule size range, low poly dispersity index, higher zeta potential, good pH value, efficient electroconductivity, classy percent of light transmittance, higher % drug content, acceptable low viscosity and carvedilol release was significantly higher (P<0.05) in dissolution rate. The carvedilol NE3 subject for further investigations. Fourier transformed infrared spectroscopy confirm no incompatibility between the drug and excipients. The atomic force microscopy study shows that system in nanoscale and has high stability. Conclusion: The selected formula (carvedilol NE3) was a promising nanoemulsion formula that increases the carvedilol solubility result in an increment of its bioavailability. © 2015, International Journal of Pharmacy and Pharmaceutical Science. All rights reserved.
Article
An attempt has been made to develop nano emulsion coatings based on Azadirachta indica (neem oil) as a replacement of organic solvent based coatings system in surface finishing industry for environmental protection, and for public health and safety. Neem oil nanoemulsion was prepared using neem oil, tween 20. A mean droplet size ranging from 31.03 - 251.43 nm, was formulated for various concentrations of oil and surfactant. The stable emulsion ratio was taken for the study. Coatings on the steel surface were done using electrophoretic deposition method. Different combinations of stabilizers were tried and characterized using AFM. The AFM images confirmed the formation of nano emulsified coatings on steel.
Article
The formulate-ability of six model active pharmaceutical ingredients (API), with different physico-chemical profiles, in a nanoemulsion designed to be intraveinously administrable was explored. Nanoemulsions were spontaneously generated at room temperature by pouring a phosphate buffer in an anhydrous mixture containing pharmaceutically acceptable triglycerides and non-ionic surfactants. After determination of the apparent solubility of each API in excipients and characterization of mixtures by DSC, API-loaded nanoemulsions were formulated and characterized in terms of granulometric properties, surface potential, drug recovery efficiency, pH, osmolarity, in vitro drug release, and stability. Except ciprofloxacin, a BCS class IV drug, all studied APIs were soluble in at least one excipient used, i.e. Labrasol(®). At 2 wt% API, all drug-loaded nanoemulsions present properties compatible with i.v. administration. The formulation should permit to increase apparent solubility of poorly water-soluble APIs, and also to prolong delivery of hydrophobic as well of more hydrophilic compounds. Herein, the relative affinity of the API for nanodroplets and the release medium would directly influence drug release profiles. Nanoemulsions were stable for 7 days. They could also been extemporaneously reconstituted before use. Such a versatile nanoemulsion would provide a valuable option as formulation strategy for improvement of drug properties.
Article
The aim of the present study was to formulate, evaluate and characterize the nanoemulsion formulation of Glipizide. Glipizide is a second generation sulphonyl urea drug used in the treatment of noninsulin dependent diabetes mellitus. It has less solubility in water and the half life of the drug is 2-4hrs.Hence by formulating Glipizide nanoemulsion the drug release will be sustained thus dosing intervals will be decreased and it eliminates the variations in the absorption. Solubility studies were conducted to select the oil, surfactant and cosurfactant. Phase diagrams were constructed by aqueous phase titration method. Formulations were selected from the phase diagrams. The prepared nanoemulsions were subjected to different thermodynamic stability tests. The results showed that all the formulations had a good stability. Based on the in vitro drug release studies the formulations were optimized. The optimized formulations were successful in sustaining the drug release for 12hrs. The optimized formulationF9 containing Capryol90 31.5%, Tween 20 15.76%, Transcutol P 32.46% and water 21.0%) optimized formulation F29containing Capryol 90 30.57%, Tween 80 11.83%, Transcutol P 35.51% and water 22.10% showed more than 85% 0f drug release in 12 hrs. The formulations were evaluated for viscosity, pH, percentage transmittance and phase separation. The formulations were also characterized for zeta potential, particle size. The droplet size of the optimized formulation (F9) was found to be 41.6nm and zeta potential was found to be -24.4mV.). Pharmacodynamic studies showed that the optimized formulation (F9) reduced blood glucose levels up to 12 hrs.
Article
Objective: The aim of this work was to formulate the antiglaucoma drug acetazolamide as ocular nanoemulsion of high therapeutic efficacy and prolonged effect.